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Background: Protocols are an essential document for conducting 
randomised controlled trials (RCTs). However, the completeness of the 
information provided is often inadequate. To help improve the 
content of trial protocols, an international group of stakeholders 
published the Standard Protocol Items: Recommendations for 
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Interventional Trials (SPIRIT) Initiative in 2013. Presently, there is 
increasing use of cohorts and routinely collected data (RCD) for RCTs 
because these data have the potential to improve efficiencies by 
facilitating recruitment, simplifying, and reducing the cost of data 
collection. Reporting guidelines have been shown to improve the 
quality of reporting, but there is currently no specific SPIRIT guidance 
on protocols for trials conducted using cohorts and RCD. This protocol 
outlines steps for developing SPIRIT-ROUTINE, which aims to address 
this gap by extending the SPIRIT guidance to protocols for trials 
conducted using cohorts and RCD.  
Methods: The development of the SPIRIT-ROUTINE extension 
comprises five stages. Stage 1 consists of a project launch and a 
meeting to finalise the membership of the steering group and scope 
of the extension. In Stage 2, a rapid review will be performed to 
identify possible modifications to the original SPIRIT 2013 checklist. 
Other key reporting guidelines will be reviewed to identify areas 
where additional items may be needed, such as the Consolidated 
Standards of Reporting Trials (CONSORT) extension 
for trials conducted using cohorts and RCD (CONSORT-ROUTINE). 
Stage 3 will involve an online Delphi exercise, consisting of two rounds 
and involving key international stakeholders to gather feedback on 
the preliminary checklist items. In Stage 4, a consensus meeting of the 
SPIRIT-ROUTINE steering group will finalise the items to include in the 
extension. Stage 5 will involve the publication preparation and 
dissemination of the final checklist.  
Conclusion: The SPIRIT-ROUTINE extension will contribute to 
improving design of trials using cohorts and RCD and transparency of 
reporting.
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Introduction
Randomized controlled trials (RCTs), the gold standard for the 
conduct of clinical research, have revolutionised the way that 
care is delivered to patients1,2. However, the frequently high 
cost of trials, the complex regulatory environment, and delays 
in incorporating trial findings into clinical practice threaten 
the ability of trials to continue to improve patient care into 
the future3–7.
A protocol is an essential document for any RCT. High qual-
ity protocols can assist efficient conduct, reporting, replica-
bility and external review8. However, the completeness of the 
information provided in trial protocols is often inadequate8. 
One study carried out by Pildal and colleagues in 2005 found 
that many trials do not have clear allocation concealment 
according to their protocol9. In an effort to improve trial report-
ing quality, an international group of stakeholders launched the 
Standard Protocol Items: Recommendations for Interventional 
Trials (SPIRIT) Initiative in 2013 to provide evidence-based 
recommendations for the minimum set of items that need to be 
included in trial protocols. The core outputs of SPIRIT are the 
SPIRIT 2013 Statement, comprising of a 33-item checklist of 
minimum suggested protocol items with a diagram and an 
Explanation and Elaboration paper10. The SPIRIT website con-
tains further information and resources11. The SPIRIT guidance 
has been instrumental in promoting high quality and transpar-
ent reporting of evaluations of interventions12. It provides the 
minimum guidance applicable for all clinical trial interven-
tions and recognises that certain interventions may require 
extension or expansion of these items9,10,12. 
In an observational cohort study, data collected from a group 
of individuals are gathered for the goal of conducting 
research13, whereas routinely collected data (RCD) refers to 
data collected for purposes other than research14. Recently, 
there is increasing interest and use of cohorts and RCD in RCTs 
because these data sources have the potential to improve 
efficiencies by facilitating recruitment, simplifying and reducing 
the cost of assessment of outcome measures and improving the 
applicability of trial findings15. Using RCD for RCTs offers 
novel concepts of testing health care interventions embed-
ded in IT systems used in routine care and fosters conducting 
large pragmatic trials16. The use of cohorts and RCD pro-
vide the potential opportunity for low-cost long-term fol-
low up minimising burden on participants17. To date, only a 
small number of trials access RCD to inform participant 
data, and few provide details on the use of such data sources18 
but designs for trials conducted using cohorts or RCD 
including administrative databases, registries, and electronic 
health records (EHRs) are increasingly used in healthcare 
evaluation. One study carried out in the UK found that almost 
fifty percent of all publicly funded trials in the UK intend to 
collect data from RCD sources19. 
The Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) statement was developed in 2004 
to help improve the transparency of reporting of observational 
research20. In response, the REporting of studies Conducted 
using Observational Routinely-collected Data (RECORD) 
statement was developed as an extension to the STROBE 
statement to help address reporting items of a particular rel-
evance to observational studies using RCD14. While, STROBE 
and RECORD have been instrumental in improving the trans-
parency of reporting of research, both STROBE and RECORD 
are only intended to apply to observational research studies14. 
Thus, the recently developed CONSORT-ROUTINE extension 
extends the CONSORT guidance to aspects of trial reporting 
specific to trials conducted using cohorts and RCD data21 
while our SPIRIT-ROUTINE extension aims to extend the 
SPIRIT guidance to protocols for trials conducted using cohorts 
and RCD. Guidance for what is expected in a protocol using 
RCD may lead to improvements in accessing data. For exam-
ple, protocols that contain governance and technical information 
typically required by a data provider to release their data, will 
arguably expedite both information governance approvals and 
data provisioning processes and potentially lead to greater use 
of RCD22,23. There is currently no specific SPIRIT guidance on 
protocols for trials conducted using cohorts and RCD5.
The aim of this project is to outline the steps for the develop-
ment of the SPIRIT-ROUTINE which will address this gap 
by extending the SPIRIT guidance for trials conducted using 
cohorts and RCD.
Methods
This project is registered with the Enhancing the QUAlity and 
Transparency Of health Research (EQUATOR) Network since 
the 5th of May 202124. The development of this SPIRIT- 
ROUTINE extension will involve using a sequential approach, 
following previously published guidance on the development 
of protocols and the EQUATOR Network methodological 
framework25, consistent with the recently developed CON-
SORT Extension for Trials Conducted Using Cohorts and 
Routinely Collected Data (CONSORT-ROUTINE)10; and simi-
lar to other SPIRIT extensions12,26. The development process 
involves 5 stages. Stage 1 consists of a project launch meeting to 
specify and finalise the scope of the extension and definition of 
cohorts and RCD. In Stage 2, a rapid review will be performed 
to identify possible modifications or new items to the original 
SPIRIT checklist. Potential items should have a specific rel-
evance to trials using cohorts or RCD. We will then identify 
items for modification and places where additional items may 
be needed by reviewing the CONSORT-ROUTINE statement. 
Stage 3 will involve an online Delphi exercise, consisting of 
two rounds and involving key stakeholders to gather feed-
back on the draft checklist items. Stage 4 will involve a con-
sensus meeting of the SPIRIT-ROUTINE team to suggest 
any new items and finalise all of the items to include in the 
extension, followed by stakeholder piloting of the checklist. 
Stage 5 will involve the publication preparation, dissemination 
and implementation of the final checklist.
Stage 1: Project launch and conceptual framework
A project operational team and a study steering committee 
have been established to deliver the project aims. The project 
operational team comprises, the lead Principal Investigator, 
Senior Research Fellow and Research Assistant. The 
SPIRIT-ROUTINE steering group was established to oversee 
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the conduct and methodology of the project and comprises 
experts in trial methodology, including members who have 
conducted trials using cohorts and RCD; experts in the devel-
opment of reporting guidelines and members of the SPIRIT 
and Trial Methodology Research Partnership (TMRP) Health 
Informatics and Outcomes working groups27. All mem-
bers of the research team will advise on each stage of the 
project and will help draft and disseminate the final guideline 
document.
Stage 2: Rapid review
To create an initial ‘long list’ of items to consider for the 
SPIRIT-ROUTINE extension reporting guideline checklist, 
items from SPIRIT 2013 will first be examined to identify 
where modifications will be needed for trials conducted using 
cohorts and RCD, and items from the CONSORT-ROUTINE 
reporting guidelines will be investigated to identify supplementary 
items to SPIRIT items.
A search of the US National Library of Medicine’s clinical 
trial registry (ClinicalTrials.gov) will then be undertaken to 
find trial protocols using cohorts and RCD in Canada and 
the US (National Institute of Health (NIH) funded US trials) 
within the last five years. In addition, a similar search of the 
National Institutes of Health Research (NIHR) journals 
library in the UK will be undertaken. Search strategies are 
available in Extended data28.
These institutes operate within different geographies but with 
broadly similar objectives. In the US, the NIH, is the “nation’s 
medical research agency and aims to seek essential knowledge 
about the nature and behaviour of living systems and the 
application of that knowledge to help improve health and 
reduce illness and disability”29. The NIHR is the UKs largest 
funder of health and care research and the NIHR Health 
Technology Assessment programme contains published trial 
reports which are of high quality and provide detailed trial 
information30,31. 
The results of each search will be individually downloaded 
into the citation management database Mendeley, and any 
duplicates will be removed. The eligibility of each proto-
col will be assessed through a two-stage process. Firstly, one 
reviewer will screen titles and abstracts. For an article to meet 
the criteria for full-text review, one reviewer must identify 
it as potentially eligible. Subsequently, a full-text review will 
be completed, with two investigators independently review-
ing each article. Discrepancies after full-text review will be 
resolved by consensus, with a third investigator consulted 
if required. If the number of protocols identified is large, we 
will select a random sample for review and data extraction. 
The eligibility criteria of each publication will be assessed as 
follows:
Inclusion criteria
     •     RCT of any type
     •     use of cohorts and RCD; and
     •     availability of a protocol
Articles which are eligible will be examined to create a long 
list of items as follows: for trial protocols that describe aspects 
of methods or reporting of trials conducted using cohorts or 
RCD, we will examine the protocols and identify areas of 
trial design that are important to report. Potential items should 
be applicable to trials using cohorts or RCD and should clar-
ify or alter an existing SPIRIT 2013 item or suggest a new 
element that should be separately reported as an item. Inves-
tigators will check elements for redundancy, and if either 
investigator or both deem it significant to report, the item 
will be included in the long list. The items identified will be 
added to an initial ‘long list’ of items, following the removal 
of duplicate records. Two investigators will independently 
extract the data from each protocol using a predesigned data 
extraction form, available in Extended data28. Before start-
ing the Delphi process, we will remove items that are evidently 
not applicable to trials using cohorts or RCD.
Stage 3: Delphi exercise
The aim of the Delphi process is to evaluate the list of items 
for consideration to be included in the SPIRIT-ROUTINE 
extension and to identify any possible items that may not have 
been identified in the review. The Delphi survey will consist of 
two rounds and invitations to participate will be sent out via 
email for each round. Participants will complete the Delphi 
survey online using the COMET DelphiManager software32 
and all participants will have a maximum of two weeks to 
complete each survey. The Delphi study participants will 
include members of the research team, clinical trialists, trial 
methodologists, guideline experts, Trial Methodology Research 
Network (TMRN) members and Patient and Public Involve-
ment (PPI) contributors; participants may be added at the rapid 
review stage (e.g., authors of published trials using cohorts 
and RCD). While no official guidance on the minimum or 
perfect panel size for Delphi studies is available, we will aim 
to include a minimum of twenty participants, as this has been 
indicated by other studies to deliver reliable results5. 
In round one, we will invite participants to rate items based 
on how valuable they are for the reporting of trial proto-
cols on a Likert scale of 1–9, which will be labelled as: 1- 3= 
‘not critical’ (items should not be part of the SPIRIT-ROUTINE 
extension checklist), 4–6= ‘no consensus’ (items should be 
discussed), 7–9 = ‘critical to include’ (item should be part of 
SPIRIT-ROUTINE extension checklist). All items rated from 
round one will be brought forward to the second round. In 
the second round, participants will be displayed the distribution 
of scores from other participants and the score that they 
attributed to each outcome, along with any comments from the 
previous round. They will be asked to reflect, and re-score if 
they want to, after having been shown the other participants’ 
views. DelphiManager enable this procedure by an easy setup 
followed by an inbuilt functionality to calculate the distribu-
tion of scores for a certain round33. In comparison to other 
online survey tools, the score distribution is then automatically 
presented to the participant in the next round and partici-
pants are reminded of their own score. Any item that is rated 
in the category ‘critical to include’ by more than 75% of the 
Delphi respondents will be deemed “consensus in”; likewise, 
if 75% or more score an item as ‘not critical’ it will be 
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deemed ‘consensus out’. Participants will also be able to 
provide feedback when they rate items and can suggest any 
additional potential items, along with a rationale. New 
items will be added to the list for the second round if two 
or more participants suggest its inclusion, and it is not deemed 
to duplicate or have any major similarities with any other 
items already in the survey28. All responses will be anony-
mous and confidential. Results of the second round of the 
Delphi exercise will be presented during a consensus meeting 
to help inform the selection of checklist items.
Stage 4: Consensus meeting and finalising items for 
inclusion
A consensus meeting will be held with members of the study 
operational team, the SPIRIT-ROUTINE steering group and 
other key stakeholders including, guideline experts, clinical 
trialists, trial methodologists and PPI contributors. This 
meeting will be held with approximately 20 participants 
to establish consensus on the items to be included in the 
SPIRIT-ROUTINE extension checklist which will include devel-
oping item explanations and assessing consistency with the 
CONSORT-ROUTINE extension. This process will involve 
presentations of items by individuals with expertise, following 
a discussion. Firstly, the items in the Delphi survey which 
reached consensus will be discussed, following any possible 
objections. Subsequently, outstanding items will then be exam-
ined, and meeting participants will be provided with the 
opportunity to discuss each item. Participants will also be 
provided with the opportunity to discuss any items excluded 
during the Delphi process and can propose better explana-
tions of any excluded items; this may involve attempting to 
alter the team’s conclusion about a particular item. We will 
arrive at consensus among meeting participants by imple-
menting anonymous voting. Items with 75% or more of voters 
voting for its inclusion will be retained.
Stage 5: Dissemination and knowledge translation
Knowledge translation is increasingly recognised to be an 
‘intensely social process’ that depends on relationships 
between those who produce research evidence and users of 
that evidence3. The emerging and existing relationships 
between the primary investigator and her research team, 
members of the TMRP and collaborators will be used to 
disseminate the SPIRIT-ROUTINE extension.
The main outcome of the proposed research will be the 
development of the SPIRIT-ROUTINE extension for trials 
which utilise cohorts and RCD. The SPIRIT-ROUTINE exten-
sion will contribute to transparent reporting of these trials. 
The investigators will register their intent to proceed with 
this exercise with the EQUATOR network, and our proposed 
extension will be listed under “Reporting Guidelines Under 
Development”24. EQUATOR is an “umbrella organization that 
brings together researchers, journal editors, peer reviewers, 
research funders, and other collaborators with a mutual 
interest in improving the quality of research”34. We will use 
knowledge translation strategies consistent with previously 
successful efforts by SPIRIT and EQUATOR and members of 
our team, the majority of whom have such experience.
Strategies for knowledge translation may include:
(1) Involvement of key stakeholders including trialists, trial 
funders, trial methodologists, guideline experts, regulators, 
TMRN and Trial Methodology Research Partnership (TMRP), 
ethics board members, and PPI contributors in the team that 
is developing the extension with an extended group being 
recruited for the Delphi process including national and 
international experts
(2) Publication of the SPIRIT-ROUTINE extension in journals
(3) Dissemination via the SPIRIT group and EQUATOR 
network, including publication on their websites
(4) Presentations at conferences (e.g. submission to 
ICTMC 2022) and focused workshops on trials embedded in 
existing data sources
(5) Dissemination via the TMRN and TMRP with delivery 
of a Clinical Research Facility-Cork (CRF C/TMRN) webinar 
on the process of the development of a SPIRIT extension
(6) Dissemination will include presentation at the HRB-TMRN 
webinar and through relevant social media channels such as 
Twitter and YouTube
Ethics statement
The proposed Delphi study abides by the ethical require-
ments of University College Cork aiming to assure rigour and 
responsibility in the conduct of research. Ethical approval for 
the Delphi survey will be sought at a later date from the Social 
Research Ethics Committee in University College Cork. 
All Delphi participants identified will be invited to complete 
each Delphi round via email. Informed consent will be 
assumed from Delphi participants who complete the survey. 
Participants will be made aware of the objectives of the 
Delphi survey in the email and that by completing the survey 
they will be giving permission for their anonymised responses 
to be used during the Delphi process, and to be accessed by 
members of the research team. Participants will also be made 
aware that their names will not be linked with the research 
materials, and will not be identifiable during the Delphi 
survey or in the reports that result from the research.
Study status
Stage 2, which involves performing a rapid review, has 
commenced.
Conclusions
This SPIRIT-ROUTINE extension for trials conducted using 
cohorts and RCD aims to promote transparency and clarity 
and to reduce research waste due to inadequate reporting. 
Consistent with the recently developed CONSORT extension 
for trials conducted using cohorts and RCD5, this SPIRIT 
extension is being carried out with the long-term goal of 
improving the quality of reporting by establishing standards 
early in the process of uptake of these trial designs.
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Data availability
Underlying data
No underlying data are associated with this article.
Extended data
Open Science Framework: The development of a SPIRIT 
extension for trials conducted using cohorts and routinely 
collected data (SPIRIT-ROUTINE). https://doi.org/10.17605/ 
OSF.IO/VQRUW28. 
This project contains the following extended data:
     •      Appendix 1. SPIRIT-ROUTINE Electronic Search 
Strategies.docx (search strategy for Stage 2).
     •      Appendix 2. SPIRIT-ROUTINE Data extraction form.doc 
(data extraction form for protocols included in Stage 2).
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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Thank you for the opportunity to review this study protocol relating to the SPIRIT extension for 
trials leveraging cohorts and routinely collected data. 
 
I enjoyed reading this paper. It is very timely and bolsters transparency and replicability in both 
trials and the observational world. I have extensive expertise in the latter, so my comments come 
from that perspective. I hope the following comments are of benefit to the development of the 
standardised reporting tool. 
 
First, a small but important point from where I sit. I feel the paper is confusing issues of design 
with the nature of data collections. Specifically, I found the reference to cohorts and RCD a bit 
jarring. Cohort studies sit squarely in the observational world and can leverage both primary and 
secondary (or routinely collected data). So, I feel it is important for the authors to be a bit clearer 
about what they mean by cohorts and RCD. Do they mean that the trials may leverage data from 
existing cohort studies (for example longitudinal cohorts that often leverage both primary and 
secondary data) and also tap into routine collections? Or something else? This point is rather 
nuanced but, for someone in my world, quite important. 
 
Again, a small point – last sentence para 3 page 4 – 50% of trials intend to collect data from RCD 
sources. RCD data are not collected, rather accessed or linked. 
 
The methodology to develop the tool is sound and aligns with best practice. I do however have a 
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couple of comments about composition of the steering group and stakeholders providing input. It 
appears that experts in the ethics, governance, linkage and analyses of RCD do not form part of 
the steering group. If there is already representation, I strongly suggest this is stated overtly. If 
not, I believe people with this expertise could add significant value and insights to the process. 
 
Stage 2. Why is the search limited to trials undertaken in the US and Canada? There are large scale 
trials linking data in other parts of the globe. Given the jurisdiction specific issues that may need 
to be addressed, I would have thought a broader search may beneficial. For example, Neal et al. 
(2021)1 is a great example of linkage to RCD in China. 
 
Stage 3: Again, I would strongly support engaging routine data experts in this phase. They are 
likely to offer important insights. There are networks such as the International Population Data 
Linkage Network that could be an appropriate vehicle here. I also note that organisations such as 
the International Society of Pharmacoepidemiology have also developed statements and guidance 
that may be useful to link into such as Pratt et al. (2019)2. 
 
I wish the SPIRIT-ROUTINE Steering Group all the very best and look forward to seeing the 
outcomes of this very important work. 
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